(Q37319736)

19 August 2017

1 reference

title

Vascular endothelial growth factor and diabetic nephropathy. (English)

1 reference

19 August 2017

0 references

Sheldon Chen

1

1 reference

19 August 2017

Fuad N Ziyadeh

series ordinal

2

1 reference

19 August 2017

publication date

1 December 2008

1 reference

19 August 2017

published in

Current diabetes report

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

470-476

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-008-0081-3

19 August 2017

exact match

0 references

cites work

Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-008-0081-3

Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.

21 January 2018

1 reference

12 December 2020

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

1 reference

12 December 2020

Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis

1 reference

12 December 2020

Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix

1 reference

12 December 2020

Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

1 reference

12 December 2020

Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

1 reference

12 December 2020

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats

1 reference

12 December 2020

Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria

1 reference

12 December 2020

Pathophysiological consequences of VEGF-induced vascular permeability

1 reference

12 December 2020

Vascular Endothelial Growth Factor in Diabetic Nephropathy

1 reference

12 December 2020

HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation

1 reference

12 December 2020

Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases

1 reference

12 December 2020

Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.

1 reference

12 December 2020

Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy

1 reference

12 December 2020

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

1 reference

12 December 2020

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy

1 reference

12 December 2020

Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes

1 reference

12 December 2020

Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.

1 reference

12 December 2020

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy

1 reference

12 December 2020

No nephropathy in Type 2 diabetic patient with POEMS syndrome with an elevated plasma VEGF.

1 reference

12 December 2020

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

12 December 2020

The regulation of the induction of vascular endothelial growth factor at the onset of diabetes in spontaneously diabetic rats

1 reference

12 December 2020

Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation

1 reference

12 December 2020

Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney

1 reference

12 December 2020

Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy

1 reference

12 December 2020

Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes

1 reference

12 December 2020

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

1 reference

12 December 2020

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

1 reference

12 December 2020

Association of VEGF-1499C→T polymorphism with diabetic nephropathy in type 1 diabetes mellitus

1 reference

12 December 2020

Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease

1 reference

12 December 2020

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

1 reference

12 December 2020

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

1 reference

12 December 2020

2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice

1 reference

12 December 2020

Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier

1 reference

12 December 2020

Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes

1 reference

12 December 2020

Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus

1 reference

12 December 2020

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

1 reference

12 December 2020

Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications

1 reference

12 December 2020

Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes

1 reference

12 December 2020

Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.

1 reference

12 December 2020

Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes

1 reference

12 December 2020

Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.

1 reference

12 December 2020

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

1 reference

12 December 2020

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats

1 reference

12 December 2020

The impairment of renal function is not associated to altered circulating vascular endothelial growth factor in patients with Type 2 diabetes and hypertension

1 reference

12 December 2020

The effect of ramipril therapy on cytokines and parameters of incipient diabetic nephropathy in patients with type 1 diabetes mellitus

1 reference

12 December 2020

10.1007/S11892-008-0081-3

Identifiers

DOI

1 reference

19 August 2017

1 reference